Triglyceride-Glucose Index Predicts Hyperuricemia in Diabetic Kidney Disease
Early identification of patients at high risk of hyperuricemia using the triglyceride-glucose index may permit prompt intervention.
Diagnosis & Disease Information
Personalized Screening for Kidney Disease Evaluated in Type 1 Diabetes
Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency
Kidney Function Declines More Slowly With SGLT2 Inhibitor
Treatment with an SGLT2 inhibitor may help patients with CKD or type 2 diabetes better preserve their kidney function.
Finerenone May Protect Against Pneumonia and COVID-19
Finerenone, a mineralocorticoid receptor antagonist, may exert anti-inflammatory and anti-fibrotic effects, according to investigators.
Consensus Reached on Treating Diabetes in Chronic Kidney Disease
The consensus report highlights shared guideline recommendations from the ADA 2022 Standards of Medical Care in Diabetes and KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
SGLT2 Inhibitors, MRA Compared for Diabetic Kidney Disease
Evidence in favor of SGLT2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists for treating patients with diabetic kidney disease is growing.
Meta-Analysis Characterizes Benefits, Risks of Novel Nonsteroidal MRAs
Blockading the mineralocorticoid receptor may be another strategy to treat CKD in patients with type 2 diabetes.
Team-Based Empowerment Care Improves Clinical Outcomes for Patients With Diabetic Kidney Disease
A multicenter randomized controlled trial was conducted to assess the impact of a web-based, diabetes evaluation portal and team-based care on outcomes in patients with diabetic kidney disease.
Post-Kidney Transplant MACE Predicts Worse Survival
Kidney transplant recipients who had nonfatal MACE within the first year after transplant surgery, compared with those who did not, had a significantly lower 1-year survival rate (80.5% vs 97.4%).
ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk
Fewer renal complications seen with tirzepatide versus insulin glargine in adults with T2D and increased cardiovascular risk
- Loading...
Loading...
Loading... 
Loading...